A Study of Oraxol in Subjects With Cutaneous Angiosarcoma
Summary
The registered summary isn't in our current data snapshot. Read it on the ClinicalTrials.gov record ↗. Why? →
Investigators
The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.
- David Cutler, MD
Athenex, Inc.
Study Director
A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.
Sites
10 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.
- Prince of Wales Hospital, Shatin
Hong Kong, Hong Kong
- National Taiwan University Hospital
Taipei, Taiwan
- Taipei Veterans General Hosptial
Taipei, Taiwan
- the Royal Marsden Nhs Foundation Trust
London, United Kingdom
- University College London Hospitals Nhs Foundation Trust
London, United Kingdom
- the Christie Nhs Foundation Trust, Manchester
Manchester, United Kingdom
- Memorial Sloan Kettering Cancer Center
New York, New York, United States
- Texas Oncology
Dallas, Texas, United States
- Md Anderson Cancer Center
Houston, Texas, United States
- University of Washington/fred Hutchinson Cancer Center
Seattle, Washington, United States
Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.
Drugs studied
No drug or biological interventions are in our data for this study — it may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →
Registration & key dates
Registry attributes as recorded on the ClinicalTrials.gov study record.
- Start
- 21 Dec 2018
- Primary completion
- 12 May 2023
- Completion
- 12 May 2023
- Last update posted
- 19 May 2023
- Registered enrollment
- 48
- Registry id
- NCT03544567
Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 12 Jul 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.